PFIZER ACCOUNTABILITY
Rhode Island sues Meta over alleged tolerance for scam advertising
The suit, filed by Rhode Island Attorney General Peter Neronha in Providence Superior Court, accuses Meta of unlawfully profiting from and participating in the creation of billions of dollars in scam advertising - even as it assured its billions of users that it was working diligently to protect them.
Pidilite shares rise marginally as company appoints Amit Agarwal CFO-designate
Pidilite Industries shares rose on Friday after the company appointed Amit Agarwal as CFO-designate and Senior Management Personnel, effective October 9, 2026. Agarwal brings over 22 years of finance experience and has previously worked with Pfizer, Hindustan Unilever and Vedanta Resources. He is a Chartered Accountant, Cost Accountant and Company Secretary.
Where Does China Fit in Your Company’s Innovation Strategy?
For decades, multinationals treated China primarily as either a vast growth market or a rising competitive threat. But as growth slows, competition intensifies, and operating conditions become more difficult, many firms are rethinking China’s role. Increasingly, they are using the country not just as a destination market but as a platform for accelerating innovation—leveraging its fast-moving regulatory environment, tightly integrated R&D and manufacturing ecosystems, and deep engineering talent pools to speed learning, validate technologies, and scale capabilities globally. Companies including Pfizer, Michelin, BMW, Bosch, and Nvidia illustrate how firms are using China to shorten innovation cycles while managing geopolitical and operational risks by defining China’s precise role within their global innovation system, designing for controlled knowledge-sharing, and avoiding overdependence through diversified R&D and supply chains.
Trump-Xi state dinner at White House attended by 21 billionaires with combined wealth almost equal to Canada’s GDP
On September 24, US President Donald Trump hosted a high-profile state dinner welcoming Chinese President Xi Jinping. The event saw the presence of over 130 distinguished guests, including key figures from the tech and business sectors of both nations. The dinner served as a platform to address vital issues, such as trade dynamics, artificial intelligence developments, and tariffs, amidst ongoing tensions.
Not an animal, but one popular fruit shares 60% of human genes. Genetic expert says it’s not shocking: ‘There’s a lot of things we do the same way…'
Who doesn’t like to munch on a banana or two during the summer? Although a guilty pleasure for those with high blood sugar levels, it remains a favourite snacking item. However, apart from being our comfort food, bananas and us are also genetically related. According to a genome study that came out in 2013, we share 60% of our DNA with this yellow fruit!
- Go To Page 1

Is severance pay received under a VRS taxable for all employees? Know what the Income Tax law says
Severance pay received under a voluntary retirement scheme is not always taxable for all employees; Know why and what the tax law says

Pfizer Q2 Results: Profit tumbles 77% to $2.3 billion; co trims 2023 revenue outlook
These include US approval for a drug combination for prostate cancer and a needed recommendation on the Abrysvo vaccine from the US Centers for Disease Control and Prevention

Pfizer Q1 results: Net profit up 61% to Rs 200 crore
Revenue from operations of the company stood at Rs 749.17 crore for the quarter under consideration. It was Rs 514.89 crore for the same period a year ago, it added.

Qatar, Oman to receive Pfizer-BioNTech COVID-19 vaccine this week
A ministry statement said people aged 16 years and above would be eligible. Qatar has also signed an agreement with drugmaker Moderna Inc to buy its vaccine.

Price of our Covid vaccine lower than Pfizer and Moderna's: Sputnik V Twitter account
"Translating pharma lingo: the announced price of Pfizer of USD 19.50 and Moderna of USD 25-USD 37 per dose actually means their price of USD 39 and USD 50-USD 74 per person. Two doses are required per person for the Pfizer, Sputnik V and Moderna vaccines. The price of Sputnik V will be much lower," the official account said.

Centrum maintains buy on Pfizer, target price Rs 5,000
Shares of Pfizer closed at Rs 4,128, up 2.5%.

Pfizer Q3 net profit zooms over two-fold to Rs 40.34 crore
The company had posted a net profit of Rs 18.37 crore for the corresponding period of the previous fiscal, Pfizer said in a BSE filing.

Pfizer to buy Allergan in $160 billion deal to create world's No 1 drugmaker
New York-based Pfizer and Allergan, headquartered in Ireland, said on Monday that Pfizer would offer 11.3 of its own shares for each Allergan share.

Pfizer, allergan in talks to forge $330bn giant: WSJ
A bid for Allergan would be Pfizer's second attempt to acquire a European rival, following its unsuccessfully courtship of AstraZeneca Plc.

Pfizer buying Hospira for about $15 billion
The deal is expected to add 10-12 cents per share to Pfizer's earnings in the first full-year after the deal closes.

Pfizer Q1 net down 85 per cent to Rs 47.63 crore
Pfizer Ltd today reported 85.51 per cent decline in the standalone net profit at Rs 47.63 crore for the first quarter ended June 30.
Pfizer may value Strides unit at Rs 10,000 crore
Pfizer's discussions with Strides Arcolab to acquire the latter's unit, Agila Specialties , is at a fairly advanced stage.

Pfizer posts Q3 net profit at Rs 63.88 crore
Net sales of the company stood at Rs 229.78 crore for the quarter under consideration against Rs 251.88 crore for the year-ago period.

Strides Arcolabs unit sale attracts Novartis, Pfizer & Kohlberg Kravis Roberts
Global drug-makers including Novartis and Pfizer are among ‘serious bidders’ considering bidding for Bangalore-based Strides Arcolabs injectable-drugs unit, Agila Specialties, two people aware of the matter said.
Biocon's corporate governance standards raise alarm among analysts
Research firm ESPIROTO SANTO Investment bank has questioned the accounting practise of Bangalore based biotechnology company Biocon.
Pfizer scraps Insulin pact with Biocon
Pfizer Inc has terminated a deal to sell Biocon's insulin products globally, dealing the Indian company a blow and calling into question similar tie-ups because of a change in the US company's strategy.
Pfizer posts Q2 net profit at Rs 46.99 crore
Net sales of the company stood at Rs 271.82 crore for the quarter ended September 30, 2011. It was Rs 225.61 crore for the quarter ended August 31, 2010, it added.
Pfizer posts Q1 net profit at Rs 41.24 crore
Shares of Pfizer Ltd were today trading at Rs 1,535.80 in the afternoon trade on BSE, up 0.02 pc from its previous close.
Pfizer posts Rs 63.14 cr profit for four months ended March
Drug firm Pfizer today reported a net profit of Rs 63.14 crore for the four month period ended March 31, 2011.
Read succeeds Kindler as Pfizer CEO
Ian C Read has been appointed as President and Chief Executive Officer (CEO) of Pfizer Inc, the US-based drug maker, succeeding Jeffrey B Kindler who has retired from the company.
Pfizer, Aurobindo ink marketing deal
PFIZER has entered into a series of agreements with Aurobindo Pharma to market medicines that are no longer patent protected and don’t have market exclusivity in US and Europe.
Pfizer to spend 300 mn dlr on R&D in Korea
Pfizer Inc, the world's biggest drugmaker, will spend $300 million on research and development in South Korea by 2012, in what the government says is the largest such investment by a foreign company.
Pfizer to spend 300 mn dlr on R&D in Korea
Pfizer Inc, the world's biggest drugmaker, will spend $300 million on research and development in South Korea by 2012, in what the government says is the largest such investment by a foreign company.
Load More